Resources by service
Harnessing effective cold chain capability to absorb the impact of mid-study protocol changes
The most successful clinical trials have one thing in common: sponsors never stop looking for ways to improve processes that support the core objective of delivering safe, compliant investigational product to patients, when and where they need it.
This was the case for one pharmaceutical company, who was working to refine its trial drug formula from frozen liquid form to lyophilised powder without disrupting its global, phase II study. Read our latest case study to learn how Almac helped the sponsor effectively manage the drug formulation change mid-trial without study interruptions or patient impact.
*By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to firstname.lastname@example.org. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.